20 July 2022 | Bacteria
Fosfomycin: as part of the consultation process new fosfomycin MIC data was submitted. The old and...
15 July 2022 | Bacteria
EUCAST still receives comments from colleagues in clinical microbiology that when organisms are...
09 July 2022 | Bacteria
The EUCAST general consultation on Corynebacterium diphtheriae and C. ulcerans is open for...
29 June 2022 | Bacteria
Warning issued concerning cefiderocol susceptibility testing: there is currently no commercially...
19 June 2022 | Bacteria
General warning against incomplete species and concentration range validation of commercially...
14 May 2022 | Bacteria
EUCAST posted a general consultation on revised breakpoints for intravenous fosfomycin....
04 May 2022 | Bacteria
EUCAST is considering removing breakpoints for piperacillin without tazobactam and/or ticarcillin...
12 April 2022 | Bacteria
The Cefiderocol Rational Document has been revised. Link.
EUCAST Rapid AST directly from positive blood culture bottles, previously restricted to 4, 6 or 8...
Minor revision of the EUCAST Guidance on topical agents
02 April 2022 | Bacteria
How to: ECOFFs—the why, the how, and the don'ts of EUCAST epidemiological cutoff...
25 March 2022 | Bacteria
For many years EUCAST and other committees have struggled with the term “intrinsic resistance”....
Looking for more information? Get in touch with an EUCAST representative today!
Contact form